Advertisement
U.S. Markets closed

Sintx Technologies, Inc. (SINT)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Visitors trend2W10W9M
3.2100+0.0300 (+0.94%)
At close: 04:00PM EDT
3.0800 -0.13 (-4.05%)
After hours: 06:48PM EDT

Sintx Technologies, Inc.

1885 West 2100 South
Salt Lake City, UT 84119
United States
801 839 3500
https://www.sintx.com

Sector(s): Healthcare
Industry: Medical Devices
Full Time Employees: 43

Key Executives

NameTitlePayExercisedYear Born
Mr. Eric K. OlsonPresident, CEO & Director359.72kN/A1963
Dr. Ryan Bock Ph.D.Chief Technology OfficerN/AN/AN/A
Ms. Ann KutschPresident of SINTX Technology Assessment & TransferN/AN/AN/A
Ms. Gina MossDirector of OperationsN/AN/AN/A
Amounts are as of December 31, 2012 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.

Corporate Governance

Sintx Technologies, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.